Antibiotic Treatment for Bacterial Prostatitis
Ciprofloxacin is the first-choice antibiotic for treating chronic bacterial prostatitis, with a recommended dosage of 500 mg twice daily for 4-6 weeks, due to its superior prostatic tissue penetration and documented efficacy. 1
Types of Bacterial Prostatitis and First-Line Treatments
Acute Bacterial Prostatitis
- First-line antibiotics:
Chronic Bacterial Prostatitis
- First-line antibiotics:
Antibiotic Selection Based on Pathogen
Common Bacterial Pathogens
- E. coli, Enterococcus, Staphylococcus:
Atypical Pathogens
Chlamydia trachomatis:
- Azithromycin 1.0-1.5 g single dose OR
- Doxycycline 100 mg twice daily for 7 days 1
Mycoplasma genitalium:
- Azithromycin 500 mg on day 1, then 250 mg for 4 days
- For macrolide-resistant strains: moxifloxacin 400 mg daily for 7-14 days 1
Ureaplasma:
- Doxycycline 100 mg twice daily for 4-6 weeks 1
Enterococcal Infections
- Treatment options:
- Daptomycin 8-12 mg/kg IV daily
- Ampicillin 200 mg/kg/day IV in 4-6 doses
- Linezolid 600 mg PO every 12 hours 1
Treatment Duration
- Acute bacterial prostatitis: 2-4 weeks (even when symptoms improve early) 1
- Chronic bacterial prostatitis: 4-6 weeks to ensure complete eradication 1
Important Considerations
Diagnostic Testing
- Midstream urine culture is essential to guide antibiotic selection 1
- The Meares and Stamey 2- or 4-glass test is strongly recommended for accurate diagnosis 1
Prostatic Penetration
- Antibiotics with good prostatic tissue penetration are crucial for effective treatment
- Fluoroquinolones, macrolides, tetracyclines, and trimethoprim have favorable pharmacokinetic properties for prostatic penetration 1
- Penicillins, cephalosporins, and aminoglycosides generally do not penetrate well into chronically inflamed prostatic tissue 3
Monitoring and Follow-up
- Clinical reassessment after 2 weeks to evaluate symptom improvement
- Urine culture at the end of treatment to confirm eradication
- Repeat PSA measurement 3 months after resolution if elevated during infection 1
Potential Complications
- Treatment failure may result from:
- Inadequate treatment duration
- Poor antibiotic selection
- Overlooking prostatic abscess
- Using antibiotics with poor prostatic penetration 1
Safety Warnings
- The FDA has issued warnings about fluoroquinolone side effects affecting tendons, muscles, joints, nerves, and central nervous system 1
- Monitor renal function and drug levels for aminoglycosides
- Weekly CPK levels for daptomycin and complete blood count for linezolid 1
Contraindications and Cautions
- Avoid prostatic massage in acute bacterial prostatitis 1
- Consider hospitalization and IV antibiotics for patients who are systemically ill, unable to urinate voluntarily, unable to tolerate oral intake, or have risk factors for antibiotic resistance 4
By selecting antibiotics with good prostatic penetration and appropriate spectrum of activity against the causative pathogens, bacterial prostatitis can be effectively treated, reducing the risk of complications and recurrence.